热门搜索:
 
当前位置: 首页 » 信息动态 » 正文

欧盟重新评估聚乙烯吡咯烷酮(E1201)和聚乙烯聚吡咯烷酮(E1202)作为食品添加剂的安全性

放大字体  缩小字体 时间:2020-08-11 09:48 来源:食品伙伴网 作者: 泽夕    浏览:351  原文:
核心提示:2020年8月10日,据欧盟食品安全局(EFSA)消息,欧盟食品添加剂和调味剂小组( FAF )重新评估了聚乙烯吡咯烷酮(polyvinylpyrrolidone)(E1201)和聚乙烯聚吡咯烷酮(polyvinylpolypyrrolidone)(E1202)作为食品添加剂的安全性并扩大聚乙烯吡咯烷酮(E1201)的使用范围。
   食品伙伴网讯  2020年8月10日,据欧盟食品安全局(EFSA)消息,欧盟食品添加剂和调味剂小组( FAF )重新评估了聚乙烯吡咯烷酮(polyvinylpyrrolidone)(E1201)和聚乙烯聚吡咯烷酮(polyvinylpolypyrrolidone)(E1202)作为食品添加剂的安全性并扩大聚乙烯吡咯烷酮(E1201)的使用范围。
 
  经过评估,专家小组认为报告的聚乙烯吡咯烷酮(E1201)和聚乙烯聚吡咯烷酮(E1202)用作食品添加剂的用途和使用水平没有安全问题。在建议的最大允许水平和建议的消费水平下,预期的扩展使用范围不会对安全造成影响。部分原文报道如下:
 
  The present opinion deals with the re‐evaluation of polyvinylpyrrolidone (E 1201, PVP ) and polyvinylpolypyrrolidone (E 1202, PVPP ) when used as food additives. One request for extension of use of PVP (E 1201) in foods for special medical purposes was also considered in this assessment. The Panel followed the conceptual framework under Commission Regulation (EU ) No 257/2010 and considered that: the exposure assessment was based on the reported use and use levels (one food category out of the two food categories in which PVP and PVPP are authorised); the 95th percentile of exposure to PVP and PVPP of maximally 23.7 and 25 mg/kg body weight (bw) per day in children, respectively, was overestimated, because it was assumed that 100% of the food supplements consumed contained PVP or PVPP at the maximum reported use levels; the extension of use of PVP (E 1201) to foods for special medical purposes (FC 13.2) would result in an exposure of PVP of 4.3 mg/kg bw per day for children; the absorption of PVP and PVPP is very low; sufficient toxicity data were available for PVP ; there is no concern with respect to the genotoxicity of PVP and PVPP ; no carcinogenic effects were reported in carcinogenicity studies in rats at a dose of 2,500 mg PVP /kg bw per day, the highest dose tested; there is no need for chronic toxicity/carcinogenicity data for PVPP for the safety assessment of PVPP given the chemical similarity between PVP and PVPP , and the lack of adverse effects in the available repeated dose toxicity studies. Therefore, the Panel concluded that there is no need for numerical acceptable daily intakes (ADI s) for PVP and PVPP , and that there is no safety concern for the reported uses and use levels of PVP and PVPP as food additives. The Panel further concluded that the proposed extension of use is not expected to be of safety concern at the proposed maximum permitted level (MPL ) and recommended consumption level.
 
  本文由食品伙伴网食品资讯中心编辑,供网友参考,欢迎转载,转载请注明出处!有任何疑问,请联系news@foodmate.net。

本文由食品伙伴网编译,供网友参考,食品伙伴网提供欧盟、美国、英国、俄罗斯、日本、韩国、东南亚、西班牙等国家或地区的进出口合规咨询服务,欢迎垂询:0535-2129301,Email:vip@foodmate.net、news@foodmate.net.

日期:2020-08-11
 

声明:

本网转载内容均已注明出处,转载目的在于传递更多信息,并不代表本网赞同其观点和对其真实性负责。
※ 如果有侵权或其他问题,请联系电话:0535-2122172

 
[ 信息动态搜索 ]  [ 告诉好友 ]  [ 打印本文 ]  [ 关闭窗口 ]

 

 
行业相关食品资讯
 
地区相关食品资讯